Invasive breast cancer risk down for female child cancer survivors
For childhood cancer survivors, the rates of invasive breast cancer have decreased over time, according to a study published online Oct. 13 in JAMA Oncology.
Oct 16, 2022
0
4
For childhood cancer survivors, the rates of invasive breast cancer have decreased over time, according to a study published online Oct. 13 in JAMA Oncology.
Oct 16, 2022
0
4
Scientists have solved a long-standing mystery surrounding a cancer-promoting protein and how it causes tumor growth. The findings are an important step in the quest to make cancer drugs more effective since aggressive tumors ...
Oct 12, 2022
0
14
October is Breast Cancer Awareness Month, which makes this a good time to learn about breast cancer types and what your type means.
Oct 5, 2022
0
29
Medicine has advanced dramatically during the last century. But when it comes to getting biopsy results, very little has changed. Consider, for example, what happens when a patient comes in to have a skin lesion biopsied ...
Sep 27, 2022
0
73
Disease-free survival (DFS) does not differ with adjuvant nivolumab plus ipilimumab (NIVO+IPI) compared with placebo in patients with localized renal cell carcinoma (RCC) at high risk for postnephrectomy relapse, according ...
Sep 14, 2022
0
9
It is a known fact that consuming a large amount of alcohol, even for a few days, triggers fat accumulation in the liver and ultimately leads to alcohol-related liver diseases. When fat accumulation occurs in the liver even ...
Sep 13, 2022
0
7
Merkel cell carcinoma is a rare but aggressive form of skin cancer that has a high rate of metastasis and poor patient outcomes. The current standard of care for patients with recurrent, unresectable or metastatic disease ...
Sep 12, 2022
0
9
TIMP-1 protein levels in both tissues and blood have been repeatedly associated with a poor prognosis in lung cancers, but its role has been unknown. Now, a study led by Jordi Alcaraz, lecturer at the Faculty of Medicine ...
Sep 12, 2022
0
24
The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of neoadjuvant immunotherapy in patients with kidney cancer. Patients with high-risk renal ...
Sep 8, 2022
0
16
A novel imaging technique significantly improves the accuracy of the diagnosis of basal cell carcinoma (BCC)—the most frequent skin cancer—compared to clinical and dermoscopic examinations alone, according to new research ...
Sep 7, 2022
0
4